MEDTOX Scientific Inc. (MTOX) Reports In-Line Q4 EPS
- Stocks Tank as QE Nears End, Major Fund Winds Down, and Ebola Fears
- Traders Eye Relational Investors Stocks on Wind Down
- David Tepper Talks Bonds, Stocks, Fannie/Freddie, Bill Gross and More
- WI-LAN (WILN) Reports Apple (AAPL) Granted Motion for Summary Judgement in Pending Litigation
- Box (BOX) Delays IPO Until 2015 Given Market Conditions - Reports
MEDTOX Scientific Inc. (NASDAQ: MTOX) reported Q4 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $25 million versus the consensus estimate of $24.49 million.
You May Also Be Interested In
- UPDATE: AZZ, Inc. (AZZ) Misses Q2 EPS Views; Affirms FY15 Outlook
- SinoCoking Coal (SCOK) Reports FY14 EPS of $0.05
- Implant Sciences Corporation (IMSC) Posts Q4 Loss of 9c/Share
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!